Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Matias Iglicki, SOE 2019 – ICO-Allergan Advanced Research Fellowship Award 2019

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 13th 2019

We caught up with Matias Iglicki, of the University of Buenos Aires, Argentina, at the SOE 2019 annual meeting. Dr Iglicki was recently awarded the ICO-Allergan Advanced Research Fellowship Award for his work in ‘Early Diagnosis of Diabetic Retinopathy Lesions using Telemedicine’, which he discusses in this video.

1. You were recently granted the ICO-Allergan Advanced Research Fellowship Award, could you tell us a bit about your research for this award? (0:04)
2. Thanks and acknowledgements (1:55)

Filmed in partnership with European Society of Ophthalmology (SOE) at the SOE 2019 meeting in Nice, France.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup